MoneyWorks4Me

Bliss GVS Pharma informs about unaudited financial results

01 Dec 2017 Evaluate

Bliss GVS Pharma has informed that the Board Meeting of the Company was held on November 30, 2017 at the registered office of the Company at 04.00 p.m. The Board considered and approved the Unaudited Standalone and Consolidated Financial Results for quarter and half year ended September 30, 2017; and Limited Review Report on Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..